COYA Stock Summary and Trading Ideas (Coya Therapeutics | NASDAQ:COYA)

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Coya Therapeutics trades on the NASDAQ stock market under the symbol COYA.

As of January 30, 2026, COYA stock price climbed to $4.65 with 249,303 million shares trading.

COYA has a beta of 1.17, meaning it tends to be more sensitive to market movements. COYA has a correlation of 0.13 to the broad based SPY ETF.

COYA has a market cap of $97.30 million. This is considered a Micro Cap stock.

Last quarter Coya Therapeutics reported $4 million in Revenue and -$.13 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.04.

In the last 3 years, COYA traded as high as $10.69 and as low as $3.21.

The top ETF exchange traded funds that COYA belongs to (by Net Assets): VTI, VXF, IWC, DFAS, DFAC.

COYA has underperformed the market in the last year with a return of -20.6%, while the SPY ETF gained +15.6%. In the last 3 month period, COYA fell short of the market, returning -24.0%, while SPY returned +2.1%. However, in the most recent 2 weeks COYA has outperformed the stock market by returning +8.6%, while SPY returned 0.0%.

COYA support price is $4.36 and resistance is $4.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COYA shares will trade within this expected range on the day.